Back to search

Article

Glucagon-like peptide-1 receptor activation and mental health: a drug-target Mendelian randomization study

2025-02-13

Abstract excerpt

Concerns have been raised about the psychiatric safety of glucagon-like peptide-1 receptor (GLP-1R) agonists, but trial evidence suggests that they ameliorate depressive symptoms. We aimed to assess the associations of GLP-1R activation with mental health well-being and the risk of mental health disorders and substance use disorders. We performed drug-target Mendelian randomization and colocalization analyses usin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
268f1176-6b0e-5567-b918-6639fff757f2
DOI
10.1101/2025.02.12.25322150
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Glucagon-like peptide-1 receptor activation and mental health: a drug-target Mendelian randomization studyDOI 10.1101/2025.02.12.25322150
Select a neighboring publication to make it the new centre.